Analysis of Common Sweeteners and Additives in Beverages with the PerkinElmer Flexar FX-15 System Equipped with a PDA Detector

Similar documents
Analysis of Isoflavones with the PerkinElmer Flexar FX-15 UHPLC System Equipped with a PDA Detector

Analysis of Cannabinoids in Cannabis by UHPLC Using PDA Detection

Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinElmer Altus UPLC System with PDA Detection

Rapid and sensitive UHPLC screening of additives in carbonated beverages with a robust organic acid column

Analysis of Cannabinoids in Hemp Seed Oils by HPLC Using PDA Detection

Analysis of Cannabinoids in Hemp Seed Oils by HPLC Using PDA Detection

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

Comparison of a UPLC Method across Multiple UHPLC Systems

ACQUITY UPLC WITH PDA DETECTION: DETERMINING THE SENSITIVITY LIMITS OF OXYBUTYNIN AND RELATED COMPOUNDS

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Effective use of Pharmacopeia guidelines to reduce cost of chromatographic analysis for Fluticasone propionate

Rapid Quantitative Analysis of Cannabidiol from Consumer Products Using UltraPerformance Convergence Chromatography

[ APPLICATION NOTE ] Profiling Mono and Disaccharides in Milk and Infant Formula Using the ACQUITY Arc System and ACQUITY QDa Detector

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

USP Method Transfer of Ziprasidone HCl from HPLC to UPLC

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Analysis of Commercially Available Products Containing Stevia

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

Impurity Profiling of Carbamazepine by HPLC/UV

Analysis of Counterfeit Antidiabetic Drugs by UHPLC with the Agilent 1220 Infinity Mobile LC

Pelagia Research Library

SIMPLE AND VALIDATED RP-HPLC METHOD FOR THE ESTIMATION OF CARBOPLATIN IN BULK AND FORMULATION DOSAGE FORM. Subhashini.Edla* B.

Analysis of Food Sugars in Various Matrices Using UPLC with Refractive Index (RI) Detection

Probing for Packaging Migrants in a Pharmaceutical Impurities Assay Using UHPLC with UV and Mass Detection INTRODUCTION

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Urine Using UHPLC-TOF

Quantitative Analysis of Carbohydrates and Artificial Sweeteners in Food Samples Using GFC- MS with APCI Interface and Post-column Reagent Addition

Fig.1. Denatonium benzoate (DB) chemical structure

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

Sanjog Ramdharane 1, Dr. Vinay Gaitonde 2

Ultra High Performance Liquid Chromatograph. Nexera X2 C196-E079

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

Maximizing chromatographic peak capacity with the Agilent 1290 Infinity LC system

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

Pelagia Research Library

Development and Validation of a RPLC Method for the Determination of 2-Phenoxyethanol in Senselle Lubricant Formulation

Journal of Chemical and Pharmaceutical Research

Rapid Screening and Quantitation of Postharvest Fungicides on Citrus Fruits Using AxION DSA/TOF and Flexar SQ MS

A HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR LERCANIDIPINE HYDROCHLORIDE

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Simultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by RP-HPLC method

Journal of Pharmacreations

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

Tentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40

Qualitative and quantitative determination of phenolic antioxidant compounds in red wine and fruit juice with the Agilent 1290 Infinity 2D-LC Solution

Extended Application Note

Application Note. Agilent Application Solution Analysis of fat-soluble vitamins from food matrix for nutrition labeling. Abstract.

Determination of Steviol Glycosides by HPLC with UV and ELS Detections

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

REVERSE PHASE HPLC METHOD FOR THE ANALYSIS OF ALFUZOSIN HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORMS

Development and validation of related substances method for Varenicline and its impurities

RP- HPLC and Visible Spectrophotometric methods for the Estimation of Meropenem in Pure and Pharmaceutical Formulations

Determination of Water- and Fat-Soluble Vitamins in Nutritional Supplements by HPLC with UV Detection

SIMULTANEOUS ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY RP-HPLC METHOD

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

Rapid Gradient and Elevated Temperature UHPLC of Flavonoids in Citrus Fruit

METHOD 8316 ACRYLAMIDE, ACRYLONITRILE AND ACROLEIN BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)

Ankit et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), Available online at RESEARCH ARTICLE

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

HPLC Analysis of Sugars

[ APPLICATION NOTE ] The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns INTRODUCTION APPLICATION BENEFITS

HPLC to UHPLC Transfer of USP Method for Amlodipine Besylate Using the Agilent 1290 Infinity II LC

New RP - HPLC Method for the Determination of Valproic acid in Human Plasma

Application Note. Small Molecule Pharmaceuticals. 2-Ethyl-2-phenylmalonamide Ethosuximide Primidone Carbamazepine. Carbamazepine-

Flupyradifurone. HPLC Method

New Solvent Grade Targeted for Trace Analysis by UHPLC-MS

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

Tramadol Hydrochloride Extended-Release Tablets. Expert Committee Chemical Medicines Monographs 2 Reason for Revision Compliance

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

Analytical Method Development for USP Related Compounds in Paclitaxel Using an Agilent Poroshell 120 PFP

Development and Validation of RP-HPLC Method for the Estimation of Gemigliptin

Journal of Chemical and Pharmaceutical Research

International Journal of Pharma and Bio Sciences

ISSN (Print)

[Application Note] TOXICOLOGY SCREENING BY UPLC/PDA IN COMBINATION WITH AN EXTENSIVE COMPOUND LIBRARY

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

Rapid determination of phosphate and citrate in carbonated soft drinks using ion chromatography

USP purity analysis of pravastatin sodium using the Agilent 1120 Compact LC

AMERICAN JOURNAL OF BIOLOGICAL AND PHARMACEUTICAL RESEARCH

Determination of taurine in energy drinks by high-performance liquid chromatography

2D-LC as an Automated Desalting Tool for MSD Analysis

Analysis of Micronutrients in Milk by Flame Atomic Absorption Using FAST Flame Sample Automation for Increased Sample Throughput

High-Resolution Analysis of Intact Triglycerides by Reversed Phase HPLC Using the Agilent 1290 Infinity LC UHPLC System

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

Available online at Scholars Research Library

CHAPTER 2 SIMULTANEOUS DETRMINATION OF ANASTROZOLE AND TEMOZOLOMIDE TEMOZOLOMIDE CAPSULES 20 MG AND ANASTROZOLE TABLETS 1 MG

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

Development and Validation of a Simultaneous HPLC Method for Quantification of Amlodipine Besylate and Metoprolol Tartrate in Tablets

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

STANDARD OPERATING PROTOCOL (SOP)

Relative Measurement of Zeaxanthin Stereoisomers by Chiral HPLC

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

Transcription:

application Note Liquid Chromatography Author Njies Pedjie PerkinElmer, Inc. Shelton, CT 06484 USA Analysis of Common Sweeteners and Additives in Beverages with the PerkinElmer Flexar FX-15 System Equipped with a PDA Detector Introduction Sweeteners are low or zero-calorie sugar substitutes that are added in drinks, processed foods and pharmaceutical products to provide the sweet taste of table sugar, which is also called sucrose. Sweeteners, especially artificial sweeteners, contain practically no calories because their metabolism follows a different pathway than that of sucrose. On the other hand, the intake of sucrose and the calories that derive from its metabolism is one of the leading causes of obesity and its related health problems including heart disease and diabetes. People with diabetes are unable to properly metabolize sucrose causing an abnormally high concentration of it in the blood stream with damaging effects on blood vessels and other vital body organs. In 2007 there were 23.6 million people in the U.S. living with diabetes with an alarming 1.6 million new cases each year at an annual cost of $174 billion. Worldwide, about 246 million people live with diabetes, with another seven million more cases each year making it a global epidemic. Substituting sucrose with artificial sweeteners, in addition to getting regular physical exercise and having healthy eating habits, is effective in fighting obesity and preventing or managing diabetes.

The use of artificial sweeteners is regulated in most countries. In the U.S., artificial sweeteners are part of the Generally Recognized As Safe (GRAS) ingredients. However, the FDA has established an Acceptable Daily Intake (ADI) for all sweeteners. Therefore manufacturers are required to list the type and amount of sweeteners on a food label. This application note presents a fast and robust liquid chromatography method to test widely used artificial sweeteners such as acesulfame potassium, saccharine and aspartame. A common stimulant and a preservative, namely caffeine and potassium benzoate were tested as well. The method was developed using a 3 µm LC column to achieve very high throughput at a low flow rate to reduce the testing time and solvent usage. The throughput was compared to that of a conventional HPLC analysis with a 5 µm particle column. In addition to throughput comparisons, method conditions and performance data including precision and linearity are presented. The results of the method applied to two popular soft drinks and two popular coffee sweeteners are reported. Experimental A working standard solution containing 200 µg/ml of acesulfame potassium, potassium benzoate, aspartame, and 100 µg/ml of saccharine and caffeine was prepared by dissolving neat material in water. Repeatability was studied with six injections of the working standard. Linearity was determined across the range of 2-200 µg/ml concentration. About 0.5 g/ml of two cola drinks from two major competitive brands were prepared by dilution with water. About of 2 mg/ml of two popular sugar substitutes were prepared individually by dissolving the sample in water followed by two min. vortexing. The solutions were thoroughly mixed and filtered with a 0.2 µm nylon membrane prior to testing. A PerkinElmer Flexar FX-15 UHPLC system fitted with a Flexar FX PDA photodiode array detector was used. The separation was achieved using a Restek Pinnacle DB C18, 3 µm, 100 x 2.1 mm column. The run time was 3.5 min with a back pressure of 6050 PSI (417 bar). Table 1. Detailed UHPLC system and chromatographic conditions. Autosampler: Flexar FX UHPLC Setting: 50 µl loop and 15 µl needle volume, partial loop mode Injection: 4 µl for UHPLC column, 10 µl for HPLC column Detector: Flexar FX PDA UHPLC Detector Analytical Wavelength: 214 nm Pump: Flexar FX-15 UHPLC Pump UHPLC Column: Restek Pinnacle DB C18, 3 µm, 100 x 2.1 mm (Cat # 9414312) HPLC Column: PerkinElmer Brownlee Analytical C-18, 5 µm, 250 x 4.6 mm (Cat #N9303514) Column Temperature: Ambient, 30 C Mobile Phase: A: 0.1% TFA in water B: 0.1% TFA in acetonitrile (HPLC grade solvent and ACS grade reagent) Conventional C18 HPLC column Time (min) Flow rate (ml/min) B % Curve 6 1.0 10-35 1 4 1.0 70 1 2 1.0 70 1 UHPLC C18 column Time (min) Flow rate (ml/min) B % Curve 3.5 0.7 5-40 1 Sampling Rate: 5 pt/s Software: Chromera Version 3.0 Results And Discussion Initially, the method was developed with a conventional C18, 250 x 4.6 mm, 5 µm particle size HPLC column. The optimal flow rate of this method was determined to be 1.0 ml/min. at ambient temperature. All the peaks eluted within 12 min. (see Figure 1). By using a shorter column with smaller particle size (C18 100 x 2.1 mm, 3 µm particle size) suitable for UHPLC, the run time was dramatically reduced from 12 min. to about 3.5 min. at 30 C (see Figure 2). In addition to the more than threefold reduction in chromatographic run time, the flow rate was reduced to 0.7 ml/min. from 1.0 ml/min. Thus, 70% reduction in testing time and 80% reduction in solvent usage was achieved by moving to the UHPLC method. This is important not only because of the relatively high cost of HPLC-grade solvents, but also because far less solvent must be disposed of as waste. This results in a much lower cost of ownership and a much greener lab operation. 2

Excellent method performance was achieved. The linearity of the analysis achieved a R-squared value of at least 0.999 for each additive tested and precisions values ranged from 0.9-1.5% RSD. Details of the method performance and results of the sample tested are presented in Table 2 and Table 3. Table 2. Precision and linearity. Acesulfame K Saccharine Caffeine Aspartame Potassium benzoate %RSD (n=6) 0.9 1.5 1.3 1.3 1.0 r² 0.9997 0.9995 0.9993 0.9993 0.9999 Range 4-200 2-100 2-100 4-200 4-200 (µg/ml) Table 3. Amount of additives in samples. Compound Cola Drink 1 Cola Drink 2 Sweetener 1 Sweetener 2 (mg/12 oz) (mg/12 oz) (mg/g) (mg/g) Acesulfame K ND ND ND ND Saccharine ND ND ND 30 Caffeine 47 35 ND ND Aspartame 181 157 40 ND Potassium benzoate 71 74 ND ND ND = None detected A spectrum of each component was obtained from the analysis of the standard solution over a range of 190 nm to 700 nm, and the wavelength maximum was determined, enabling the selection of a suitable wavelength setting for the analysis. PerkinElmer s Chromera software helps in assessing the purity of each peak by comparing the spectra on the upslope and the down slope of the peak. Because a pure peak has matching spectra throughout the peak, a ratio of upslope/down slope absorbance greater than 1.5 could be an indication of a co-elution. The spectrum and the purity of one of the sweeteners tested are presented in Figure 3. Although in liquid chromatography peak identification is usually based on the retention time, Chromera s ability to collect and store spectra offers another way of identification by matching any peak spectrum to spectra stored in its library. This feature of Chromera adds another level of confidence in the analysis as the same relative retention time does not necessarily mean the components are the same. Confirmation of the presence of caffeine, aspartame and potassium benzoate in the Cola Drink 1 sample is shown in Figure 4. In that figure, the spectra at the peak apex of each peak is compared with the spectra of the standard stored in the library. When a match is made, the name of the matching spectrum appears on each peak in question, confirming its identity. 3

Figure 1. Chromatogram from the analysis of a standard with conventional HPLC C18 250 x 4.6 mm, 5 µm column. Figure 2. Chromatogram from the analysis of a standard UHPLC C18 100 x 2.1 mm, 3 µm column. Figure 3. Chromatogram of the analysis of Sweetener 1 and the assessment of the peak purity. Conclusion The application of UHPLC to the analysis of artificial sweeteners and soft drink additives resulted in 70% reduction in run time, as well as 80% reduction in solvent usage. The PerkinElmer Flexar FX-15 UHPLC system and Restek Pinnacle DB C18, 3 µm, 100 x 2.1 mm resolved all five additives studied in about three and half minutes. The method was shown to be linear and the peaks were well resolved. Both of the soft drinks tested were sweetened with aspartame: 181 mg/12 oz for Cola Drink 1 and 157 mg/ 12 oz for Cola Drink 2. The level of caffeine in drinks was similar to the label claim of 45 mg/12 oz for Cola Drink 1 and 35 mg/12 oz for Cola Drink 2. Both of the drinks have similar amounts of potassium benzoate: 71 mg/12 oz for Cola Drink 1 and 74 mg/12 oz for Cola Drink 2. The PerkinElmer 4

Figure 4. Chromatogram of the Cola Drink 1 and spectra library confirmation. FX PDA detector provides rugged and accurate detection over a range of 190 nm to 700 nm, encompassing UV and visible wavelengths. PerkinElmer s Chromera software offers many data acquisition and processing features: spectral library creation, and peak purity, spectra 3D and contour maps, which are powerful tools for interrogating the information content of a 3D photodiode array chromatogram. The spectra library search function allowed the storage of standard peaks spectra that were later used for peak identification confirmation in the sample. References 1. American Diabetes Association. 2007 National Diabetes Facts; Standards of Medical Care in Diabetes 2008; Diabetes Care. 2009; 32:S13-S61, 2009. 2. FDA, Generally Recognized As Safe (GRAS) 21 CFR 170.30(b), 170.30(c) and 170.3(f). 3. Leo M.L. Nollet. Food Analysis by HPLC. Marcel Dekker, NY, 2000, pp. 523-565. 4. Food Ingredient and Colors, IFIC and FDA, November 2004, revised 2010. 5. International Diabetes Federation, Diabetes Epidemic Facts. PerkinElmer, Inc. 940 Winter Street Waltham, MA 02451 USA P: (800) 762-4000 or (+1) 203-925-4602 www.perkinelmer.com For a complete listing of our global offices, visit www.perkinelmer.com/contactus Copyright 2010, PerkinElmer, Inc. All rights reserved. PerkinElmer is a registered trademark of PerkinElmer, Inc. All other trademarks are the property of their respective owners. 009473_01